2866
A. SAMADI ET AL.
124.2 (C3), 60.7 (CH2), 45.5 (2 ꢁ CH3); MS (EI) m=z (%): 170 (34) [M]þ, 135 (43)
[M ꢂ Cl]þ, 126 (55) [M – NMe2]þ.
2-N,N-Dimethylamino-5-[(N,N-dimethylamino)methyl]pyridine
(15).
Following the general procedure and starting from precursor 4 (215.5 mg, 1.5 mmol),
compound 15 (196 mg, 73%) was obtained as a light yellow solid: Rf ¼ 0.07 (CH2Cl2=
MeOH, 10=1, v=v); mp 187–189 ꢀC; IR (KBr) n 3412, 2930, 2662, 1611, 1520,
1
1403 cmꢂ1; H NMR (300 MHz, CDCl3) d 8.05 (d, J ¼ 2.4 Hz, H6, 1H), 7.91 (dd,
J ¼ 8.9 and 2.5 Hz, H4, 1H), 6.56 (d, J ¼ 8.9 Hz, H3, 1H), 3.99 (s, 2H, CH2), 3.09
(s, 6H, NMe2), 2.69 (s, 6H, NMe2); 13C NMR (75 MHz, DMSO-d6) d 159.6 (C2),
149.8 (C6), 139.6 (C4), 111.2 (C5), 106.2 (C3), 58.7 (CH2), 41.6 (2 ꢁ CH3), 37.9
(2 ꢁ CH3); MS (EI) m=z (%): 179 (19) [M]þ, 135 (100) [M - NMe2]þ. Anal. calcd.
for C10H17N3: C, 67.00; H, 9.56; N, 23.44. Found: C, 66.91; H, 9.44; N, 23.32.
2-Amino-6-(N,N-dimethylamino)-4-phenylpyridine-3,5-dicarbonitrile
(18). Following the general procedure and starting from precursor 8 (190 mg,
1.5 mmol) compound 18 was obtained as a white solid (0.145 g, 74%): Rf ¼ 0.63
(CH2C2=AcOEt, 10=1, v=v); mp 251–253 ꢀC; IR (KBr) n 3473, 3320, 3221, 2210,
1
1624, 1586, 1570, 1550, 1515, 1491, 1420, 1400, 1228 cmꢂ1; H NMR (300 MHz,
CDCl3) d 7.43–7.54 (m, 5 ꢁ CH-ar), 735 (s, NH2, 2H), 3.21 (s, 6H, 2 ꢁ CH3); 13C
NMR (75 MHz, DMSO-d6) d 162.4 (C), 160.6 (C), 159.8 (C), 135.9 (C), 130.3
(CH), 129.1 (2 ꢁ CH), 129.0 (2 ꢁ CH), 118.5 (CN), 116.8 (CN), 81.0 (C-CN), 80.6
(C-CN), 40.46 (2 ꢁ CH3); MS (EI) m=z (%): 262 (110) [M – H]þ, 263 (50) [M]þ. Anal.
calcd. for C15H13N5 (263.117): C, 68.42; H, 4.98; N, 26.60. Found: C, 68.19; H, 4.90;
N, 26.31.
2-(N,N-Dimethylamino)-6-chloropyridine (19). Following the general pro-
cedure and starting from precursor 9 (220 mg, 1.5 mol), compound 19 (228 mg, 98%)
was obtained as a yellow oil: Rf ¼ 0.2 (hexane=CH2C2, 3=2, v=v); 1H NMR
(300 MHz, CDCl3) d 7.35 (dd, J ¼ 8.4 and 7.5 Hz, H4, 1H), 6.51 (d, J ¼ 7.4 Hz,
H3, 1H), 6.34 (d, J ¼ 8.4 Hz, H5, 1H), 3.06 (s, 6H, NMe2); 13C NMR (75 MHz,
DMSO-d6) d 159.4 (C2), 149.5 (C6), 139.5 (C4), 110.5 (C5), 103.8 (C3), 38.2
(2 ꢁ CH3); MS (EI) m=z (%): 156 (65) [M]þ, 141 (87) [M ꢂ Me]þ; 127 (100)
[M ꢂ 2CH3]þ.
2,6-Bis-(N,N-dimethylamino)pyridine-3,5-dicarbonitrile (21). Following
the general procedure and starting from precursor 10 (48.2 mg, 0.24 mmol), com-
pound 21 was obtained after 1 min of microwave irradiation as a light yellow solid
(32.4 mg, 92%): Rf ¼ 0.23 (hexane=ethyl acetate 3:1, v=v); mp 170–172 ꢀC; IR
1
(KBr) n 2935, 2202, 1603, 1526 cmꢂ1; H NMR (400 MHz, DMSO-d6) d 8.04 (s,
1H, H-4py, 1H), 3.20 (12 H, s, 4 N-CH3); 13C NMR (100 MHz, DMSO-d6) d
156.9 (C-2, C-6 py), 153.0 (C-4 py), 118.8 (2 CN), 78.90 (C-3, C-5 py), 39.6 (4
CH3); MS (EI) m=z (%): 215 (100) [M]þ, 200 (39) [M – CH3]þ, 186 (99) [M ꢂ
2CH3 þ H]þ. Anal. calcd. for C11H13N5: C, 61.38; H, 6.09; N, 32.54. Found: C,
61.22; H, 5.91; N, 32.36.
2,6-Bis-(N,N-dimethylamino)-4-phenylpyridine-3,5-dicarbonitrile (22).
Following the general procedure and starting from precursor 11, compound 22
was obtained after 1 min of microwave irradiation as a white solid (90.7 mg, 54%):